NDTVCenter·
Cipla Q2 Preview: Net Profit Seen Falling 29% As US Business Faces Headwinds
Analysts estimate the pharmaceutical company's consolidated revenue to rise just 0.6% year on year.
Read at NDTV →
Analysts estimate the pharmaceutical company's consolidated revenue to rise just 0.6% year on year.

<iframe src="https://hindustansphere.com/embed/cluster/24a5114f1321cef12f10a63400fef374e594d76e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Cipla Q2 Preview: Net Profit Seen Falling 29% As US Business Faces Headwinds"></iframe>
